Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Interleukin enhancer-binding factor 3 (ILF3) (AA 785-894) antibody

ILF3 Reactivity: Human WB, IHC, ELISA Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7156720
  • Target See all Interleukin enhancer-binding factor 3 (ILF3) Antibodies
    Interleukin enhancer-binding factor 3 (ILF3)
    Binding Specificity
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 785-894
    Reactivity
    • 56
    • 40
    • 37
    • 14
    • 11
    • 11
    • 10
    • 5
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    Human
    Host
    • 52
    • 2
    • 1
    Rabbit
    Clonality
    • 45
    • 11
    Polyclonal
    Conjugate
    • 42
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Un-conjugated
    Application
    • 36
    • 16
    • 10
    • 10
    • 9
    • 9
    • 5
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
    Cross-Reactivity
    Human
    Purification
    Antigen Affinity Purified
    Immunogen
    Recombinant Human Interleukin enhancer-binding factor 3 protein (785-894AA)
    Isotype
    IgG
    Top Product
    Discover our top product ILF3 Primary Antibody
  • Application Notes
    Recommended dilution: WB:1:200-1:1000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    Interleukin enhancer-binding factor 3 (ILF3)
    Alternative Name
    ILF3 (ILF3 Products)
    Synonyms
    CBTF antibody, DRBF antibody, DRBP76 antibody, MMP4 antibody, MPHOSPH4 antibody, MPP4 antibody, NF-AT-90 antibody, NF110 antibody, NF110b antibody, NF90 antibody, NF90a antibody, NF90b antibody, NFAR antibody, NFAR-1 antibody, NFAR2 antibody, TCP110 antibody, TCP80 antibody, MBII-26 antibody, ilf3 antibody, wu:fb37d07 antibody, wu:fb94b02 antibody, zgc:77030 antibody, 4F.1 antibody, cbtf122 antibody, ilf3-A antibody, ubp3 antibody, ubp4 antibody, xilf3 antibody, interleukin enhancer binding factor 3 antibody, interleukin enhancer binding factor 3b antibody, interleukin enhancer binding factor 3 S homeolog antibody, ILF3 antibody, Ilf3 antibody, ilf3b antibody, ilf3.S antibody
    Background

    Background: May facilitate double-stranded RNA-regulated gene expression at the level of post-transcription. Can act as a translation inhibitory protein which binds to coding sequences of acid beta-glucosidase (GCase) and other mRNAs and functions at the initiation phase of GCase mRNA translation, probably by inhibiting its binding to polysomes. Can regulate protein arginine N-methyltransferase 1 activity. May regulate transcription of the IL2 gene during T-cell activation. Can promote the formation of stable DNA-dependent protein kinase holoenzyme complexes on DNA. The phosphorylated form at Thr-188 and Thr-315, in concert with EIF2AK2/PKR can inhibit vesicular stomatitis virus (VSV) replication (By similarity).

    Aliases: CBTF antibody, Double stranded RNA binding protein 76 antibody, Double-stranded RNA-binding protein 76 antibody, DRBF antibody, DRBP76 antibody, ILF3 antibody, ILF3_HUMAN antibody, Interleukin enhancer binding factor 3 antibody, Interleukin enhancer-binding factor 3 antibody, M phase phosphoprotein 4 antibody, M-phase phosphoprotein 4 antibody, MPHOSPH4 antibody, MPP4 antibody, NF AT 90 antibody, NF-AT-90 antibody, NF110 antibody, NF90 antibody, NFAR antibody, Nuclear factor associated with dsRNA antibody, Nuclear factor of activated T cells 90 kDa antibody, Nuclear factor of activated T-cells 90 kDa antibody, TCP80 antibody, Translational control protein 80 antibody

    UniProt
    Q12906
    Pathways
    M Phase
You are here: